Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Videos | Heart Valve Technology

Torsten Vahl, M.D., director of experimental and translational research, Structural Heart and Valve Center and at the ...

Home October 09, 2019
Home
News | Stent Grafts

October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug ...

Home October 09, 2019
Home
News

October 9, 2019 — Medtronic is recalling the 6 French Sherpa NX Active Guide Catheter due to a risk of the outer ...

Home October 09, 2019
Home
News | Stent Grafts

October 8, 2019 — PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) ...

Home October 08, 2019
Home
Videos | Antiplatelet and Anticoagulation Therapies

American Heart Association President Robert Harrington, M.D., interventional cardiologist and the Arthur L. Bloomfield ...

Home October 08, 2019
Home
Videos | Cardiogenic Shock

William O’Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit ...

Home October 08, 2019
Home
360 Photos | 360 View Photos

Henry Ford Hospital in Detroit gets a lot of referrals for very sick patients seeking a last resort treatment in its ...

Home October 08, 2019
Home
Videos | TCT

Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from the 2019 Transcatheter ...

Home October 04, 2019
Home
News | Heart Valve Technology

October 4, 2019 – A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-year ...

Home October 04, 2019
Home
News | Heart Failure

October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...

Home October 04, 2019
Home
News

October 4, 2019 – RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced ...

Home October 04, 2019
Home
News | Heart Valve Technology

October 3, 2019 – Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and ...

Home October 03, 2019
Home
People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019
Feature | Cath Lab

October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...

Home October 03, 2019
Home
News | Heart Failure

October 3, 2019 – The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...

Home October 03, 2019
Home
Videos | University of Colorado Hospital

Interview with John Carroll, M.D., director of interventional cardiology, Robert Quaife, M.D., director of advanced ...

Home October 02, 2019
Home
Subscribe Now